Where are they now? The startups that succeeded or failed in the last 20 years
As part of our 20th anniversary celebration, we find out what happened to some of the most promising startups we featured in our early days.
As part of our 20th anniversary celebration, we find out what happened to some of the most promising startups we featured in our early days.
12 patients are receiving Kamada’s immunoglobulin for coronavirus disease; so far, three patients were well enough to go home from the hospital.
Israeli scientists, doctors, innovators, and CEOs are working quickly, with purpose, and fully aware of the huge responsibility they are undertaking.
Kamada releases first batch of its immunoglobulin product for coronavirus disease, plans clinical study on hospitalized patients.